Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Colosseum Group is a private startup studio, incubator, and investment group founded in 2004. The company describes itself as a global brand operating across the Americas, EMEA, and Asia, with activities spanning investments, incubation, engineering, design, research, education, and nonprofit initiatives. Its business appears to center on helping early-stage companies move from idea formation through product design, development, and go-to-market support. Publicly available information indicates that it has invested in multiple startups, including at least one healthcare AI company, but Colosseum Group itself does not appear to be a dedicated biotech, pharma, or healthcare operating company. For biotech analyst purposes, it is best characterized as a diversified venture-building and investment organization rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Colosseum Group.